August 18th, 2008

Lexicon initiates preclinical development of new drug candidate for glaucoma (PharmaBiz)

Lexicon Pharmaceuticals, Inc, a biopharmaceutical company, announced that it has initiated formal preclinical development of LX7101, a new drug candidate for glaucoma.

Filed under: IBS




Digestive Disorders


Leave a Reply

« Bicyclists volunteer for a Gut Check (Rapid City Journal) Ask Dr. Gott: To heal mouth sores, cut acidic foods (The Monterey County Herald) »

  • Subscribe To Digestive Disorders RSS

  • Subscribe
  • Add to Google Reader or Homepage
  • Subscribe in NewsGator Online
  • Add to My AOL
  • Subscribe in Bloglines
  • Add to Excite MIX
  • Get Free Traffic Secrets!